Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds as antagonists or inverse agonists at opioid receptors

Compounds as antagonists or inverse agonists at opioid receptors

US Patent 8633175 · Granted Jan 21, 2014

Estimated economic value: $37,407,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR inhibitors for the treatment of cancer2025
Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH2025
Compounds2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025
Isoquinoline compounds and their use in treating AhR imbalance2025
Anticancer compounds2024
MrgX2 antagonists2024
Isoquinoline compounds and their use in treating AhR imbalance2023
C-mannoside compounds useful for the treatment of urinary tract infections2023
Oxaborole analogs and uses thereof2023
Isoquinoline compounds and their use in treating AhR imbalance2023
Synthetic process and intermediates2022